StonvexLoading…
StonvexStonvexStonvexCore line items from KRYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $389.13M | $290.51M | $50.70M | $0.00 |
Operating Income | $161.29M | $65.75M | $-109.62M | $-145.20M |
Net Income | $204.83M | $89.16M | $10.93M | $-139.97M |
EPS (Diluted) | $6.84 | $3.00 | $0.39 | $-5.49 |
Total Assets | $1.33B | $1.06B | $818.36M | $558.45M |
Total Liabilities | $114.23M | $109.46M | $39.71M | $36.22M |
Cash & Equivalents | $496.30M | $344.87M | $358.33M | $161.90M |
Free Cash Flow OCF − CapEx | $188.91M | $119.18M | $-100.60M | $-153.55M |
Shares Outstanding | 29.19M | 28.79M | 28.24M | 25.76M |